symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
CDIO,0.261,0,284621,3073588,0,0.23-10.195,0.001,"Cardio Diagnostics Holdings, Inc.",USD,0001870144,,,NASDAQ Capital Market,NASDAQ,Biotechnology,https://cardiodiagnosticsinc.com,"Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.",Dr. Meeshanthini V. Dogan Ph.D.,Healthcare,US,7,855 226 9991,400 N Aberdeen St,Chicago,IL,60642,,0,https://financialmodelingprep.com/image-stock/CDIO.png,2022-01-14,True,False,True,False,False
